Kiora Pharmaceuticals, Inc. (KPRX)

NASDAQ: KPRX · Real-Time Price · USD

1.980

-0.050 (-2.46%)

At close: Mar 6, 2026, 4:00 PM EST

2.030

+0.050 (2.53%)

After-hours: Mar 6, 2026, 7:47 PM EST

Kiora Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	5.51	3.79	2.45	5.96	7.85	1.19
Short-Term Investments	13.87	23	-	-	-	-
Cash & Short-Term Investments	19.38	26.79	2.45	5.96	7.85	1.19
Cash Growth	-99.93%	991.47%	-58.85%	-24.06%	562.47%	-68.61%
Accounts Receivable	1.21	0.6	-	-	-	-
Other Receivables	1.45	0.27	2.05	1.37	0.53	0.09
Total Trade Receivables	2.67	0.87	2.05	1.37	0.53	0.09
Other Current Assets	0.65	2.04	0.23	0.34	0.61	0.45
Total Current Assets	22.69	29.71	4.74	7.68	8.99	1.73
Net Property, Plant & Equipment	0.42	0.06	0.11	0.17	0.28	0.11
Other Intangible Assets	6.69	6.69	8.81	10.74	10.77	13.36
Other Long-Term Assets	0.06	0.03	0.05	0.08	0.09	0.1
Total Assets	29.86	36.48	13.71	18.68	20.13	15.3
Accounts Payable	0.24	0.42	0.21	1.01	0.16	0.43
Accrued Expenses	2.15	4.59	1.38	1.84	1.33	1.29
Short-Term Debt	-	-	-	-	-	0.21
Current Portion of Leases	0.16	0.02	0.05	0.11	0.12	0.05
Other Current Liabilities	0.03	0.98	-	0.32	-	-
Total Current Liabilities	2.58	6.01	1.63	3.27	1.61	1.98
Long-Term Debt	-	-	-	-	-	0.28
Long-Term Leases	0.25	0.03	0.06	-	0.09	0.04
Other Long-Term Liabilities	4.62	4.68	5.91	4	3.85	3.28
Total Long-Term Liabilities	4.87	4.72	5.97	4	3.94	3.59
Total Liabilities	7.45	10.72	7.6	7.27	5.55	5.57
Preferred Stock	0	0	-	-	-	0
Common Stock	0.27	0.27	0.08	0.02	0	0.06
Additional Paid-in Capital	170.08	169.16	153.19	146.04	135.54	116.78
Accumulated Other Comprehensive Income	-0.24	-0.28	-0.18	-0.18	-0.09	-0
Retained Earnings	-147.7	-143.38	-146.98	-134.46	-120.88	-107.11
Shareholders' Equity	22.41	25.76	6.11	11.41	14.58	9.73
Total Liabilities & Equity	29.86	36.48	13.71	18.68	20.13	15.3
Total Debt	0.4	0.06	0.11	0.11	0.21	0.57
Net Cash (Debt)	18.97	26.73	2.35	5.86	7.65	0.61
Net Cash Growth	-29.04%	1038.72%	-59.93%	-23.37%	1150.70%	-83.45%
Net Cash Per Share	4.52	6.48	4.36	72.00	285.39	47.93
Book Value	22.41	25.76	6.11	11.41	14.58	9.73
Book Value Per Share	5.34	6.24	11.36	140.20	544.22	762.87
Tangible Book Value	15.72	19.07	-2.7	0.66	3.81	-3.63
Tangible Book Value Per Share	3.75	4.62	-5.03	8.17	142.26	-284.74

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q